Explore the vast range of titles available.

The Mediterranean dietary pattern has been associated with a decreased risk of many degenerative diseases and cognitive function in particular; however, relevant information from Mediterranean regions, where the prototype Mediterranean diet is typically adhered to, have been very limited. Additionally, predefined Mediterranean diet (MeDi) scores with use of a priori cut-offs have been used very rarely, limiting comparisons between different populations and thus external validity of the associations. Finally, associations between individual components of MeDi (i.e., food groups, macronutrients) and particular aspects of cognitive performance have rarely been explored. We evaluated the association of adherence to an a priori defined Mediterranean dietary pattern and its components with dementia and specific aspects of cognitive function in a representative population cohort in Greece. Participants from the Hellenic Longitudinal Investigation of Ageing and Diet (HELIAD), an on-going population-based study, exploring potential associations between diet and cognitive performance in a representative sample from Greek regions, were included in this analysis. Diagnosis of dementia was made by a full clinical and neuropsychological evaluation, while cognitive performance was assessed according to five cognitive domains (memory, language, attention-speed, executive functioning, visuospatial perception) and a composite cognitive score. Adherence to MeDi was evaluated by an a priori score (range 0-55), derived from a detailed food frequency questionnaire. Among 1,865 individuals (mean age 73±6 years, 41% male), 90 were diagnosed with dementia and 223 with mild cognitive impairment. Each unit increase in the Mediterranean dietary score (MedDietScore) was associated with a 10% decrease in the odds for dementia. Adherence to the MeDi was also associated with better performance in memory, language, visuospatial perception and the composite cognitive score; the associations were strongest for memory. Fish consumption was negatively associated with dementia and cognitive performance positively associated with non-refined cereal consumption. Our results suggest that adherence to the MeDi is associated with better cognitive performance and lower dementia rates in Greek elders. Thus, the MeDi in its a priori constructed prototype form may have cognitive benefits in traditional Mediterranean populations.

Although research has generally shown a negative association between depression and adherence to the Mediterranean diet (MeDi), the literature related to older adults is controversial, perhaps partially due to the fact that cognitive status has not been considered. The aim of the current work was to investigate the association between MeDi and incident depression in a representative cohort of people, taking into account their cognitive status in multiple ways. The sample was drawn from the HELIAD study, a longitudinal study including a follow-up of 3 years after the baseline assessment. In total, 879 participants without depression at baseline were included (55.4% women, mean age ± Standard Deviation: 73.3 ± 5.0 years). Depression was determined as a score in the Geriatric depression scale ≥6 and/or antidepressant medication and/or clinical diagnosis of depression. Cox proportional hazard models adjusted for age, sex and education were employed. In the basic model, adherence to the MeDi was negatively associated with depression. In the most conservative model, excluding participants with dementia and Mild Cognitive Impairment, and after controlling for the baseline Cognitive Status, each unit (range 0–55) increase in MeDi was associated with a 6.2% decrease in the risk for depression (p < 0.001). These findings indicate that MeDi is negatively associated with depression longitudinally in older adults, above and beyond cognitive status.

Background Short sleep duration and low sleep quality are negatively associated with obesity in young adults, but in older people the results are inconsistent. Aims The aim of the present study was to examine the associations between sleep duration and quality with both body mass index (BMI) and waist circumference (WC) and to investigate sex- and age-specific associations in a population-representative cohort of older adults. Methods 1781 participants ≥ 65 years old from the HELIAD study were included. Sleep duration and quality were based on self-report, whereas BMΙ and WC were evaluated clinically. Results Sleep duration was inversely related to WC, only in women, even after adjustment for age, sex, years of education, total energy intake and level of physical activity. Furthermore, sleep quality was negatively related to both BMI and WC in women. In men, however, no significant relationships were observed between these variables. Associations between sleep and weight did not differ between those aged < 73 and ≥ 73 years old. Discussion To the best of our knowledge, this is the first study examining both sleep duration and quality with BMI and WC in older adults, performing by-sex analysis. Although additional studies are needed, improvements in sleep habits should be considered in weight management of older individuals. Conclusions Our results suggest that poor sleep is associated to adverse weight effects in older women, but not men.

Background and objectives: Given the rapid increase of older people, especially of the older elderly, the investigation of modifiable factors that can affect healthy ageing, including diet, is of paramount importance. The aim of the present study was to explore the adherence to an a priori defined Mediterranean dietary pattern, as well as the consumption of specific food groups, in younger elderly compared to older elderly adults in a large population-representative sample in Greece. Methods: Participants from the Hellenic Longitudinal Investigation of Ageing and Diet (HELIAD) were included. The sample consisted of adults ≥65 years old, and was stratified by age, i.e. those aged ≤75 years old and those aged >75 years old, representing the younger and the older elderly, respectively. Habitual diet during the previous month was assessed using a validated semi-quantitative food frequency questionnaire whereas adherence to the Mediterranean Diet was assessed by an a priori score, the MedDietScore. Results: Among 1835 individuals, 1249 participants were ≤75 years old and 586 >75 years old. Energy and macronutrient intake did not differ by age group. The younger elderly consumed more fruits, vegetables, fish as well as coffee/tea and fewer refined cereals compared to the older elderly. However, when total energy intake, sex and years of education were entered as covariates, the association remained significant only for fruits, vegetables and coffee/tea (B=-0.098, p=0.023, B=-0.094, p<0.001 and B=-0.079, p=0.001, respectively). Furthermore, the younger elderly adhered more closely to the Mediterranean diet compared to the older elderly even when covariates were entered (B=-0.092, p<0.001). Conclusions: Our results suggest that the younger elderly adhere more closely to the Mediterranean diet than the older elderly. Although additional studies are needed, the results are valuable in order to design tailored interventions in terms of public health policy that take into account the special characteristics and needs of the different age groups among older people.

Restless legs syndrome (RLS) (or Willis–Ekbom disease) is a neurological disorder with high prevalence among the end-stage renal disease population. This is one of the most predominant types of secondary RLS, and it is called uremic RLS. Despite the fact that uremic RLS has been less studied compared to idiopathic RLS, recent studies now shed light in many aspects of the syndrome including clinical characteristics, impact, epidemiology, and treatment options. The current review discusses the above topics with special emphasis given on the management of uremic RLS, including the management of symptoms that often appear during a hemodialysis session. Uremic RLS symptoms may be ameliorated by using pharmacological and nonpharmacological treatments. Evidence so far shows that both approaches may be effective in terms of reducing the RLS symptom’s severity; nevertheless, more research is needed on the efficiency of treatments for uremic RLS.

Sleep disorders are prevalent among the general population and even more in individuals suffering from chronic diseases. Recent data reveal promising effects of physical exercise as a non-pharmacological approach for improving sleep and managing various sleep disorders. However, more studies with proper design and methodology should be conducted in the future to obtain a clearer understanding of the subject. The role of exercise in preventing and improving sleep disorders is probably much higher than what is currently exploited. To fully exploit the potential benefit of physical activity on sleep disorders in the future, it is necessary to identify the relevant tools to assess sleep–wake disorders and establish specific exercise protocols tailored to different sleep disorders. The present manuscript aims to review the literature on the use of exercise in managing selected sleep disorders. Regular exercise, including short-term aerobic activity, resistance training, and mind–body exercises, can effectively improve sleep quality, particularly in cases of insomnia and sleep-disordered breathing. Additionally, increasing evidence supports the effectiveness of aerobic and strength training, and body-mind exercises such as yoga in managing sleep-related movement disorders. Exercise can be a safe, affordable, and efficient tool in enhancing sleep quality and improving sleep disorders. Per se, regular exercise could play an adjuvant role alongside with established therapies, or a valid alternative when the pharmacological approach is limited by side effects, interactions, or inefficacy. More research is needed to define how exercise affects the physiology of sleep, and consequently how to use exercise in patients with sleep disorders.

Restless Legs Syndrome is a very common disorder in hemodialysis patients. Restless Legs Syndrome negatively affects quality of life; however it is not clear whether this is due to mental or physical parameters and whether an association exists between the syndrome and parameters affecting survival. METHOD#ENTITYSTARTX003BF;LOGY/PRINCIPAL FINDINGS: Using the Restless Legs Syndrome criteria and the presence of Periodic Limb Movements in Sleep (PLMS/h >15), 70 clinically stable hemodialysis patients were assessed and divided into the RLS (n = 30) and non-RLS (n = 40) groups. Physical performance was evaluated by a battery of tests: body composition by dual energy X ray absorptiometry, muscle size and composition by computer tomography, while depression symptoms, perception of sleep quality and quality of life were assessed through validated questionnaires. In this cross sectional analysis, the RLS group showed evidence of thigh muscle atrophy compared to the non-RLS group. Sleep quality and depression score were found to be significantly impaired in the RLS group. The mental component of the quality of life questionnaire appeared significantly diminished in the RLS group, reducing thus the overall quality of life score. In contrast, there were no significant differences between groups in any of the physical performance tests, body and muscle composition. The low level of quality of life reported by the HD patients with Restless Legs Syndrome seems to be due mainly to mental health and sleep related aspects. Increased evidence of muscle atrophy is also observed in the RLS group and possibly can be attributed to the lack of restorative sleep.

Osmotic demyelination syndrome (ODS), which embraces central pontine and extrapontine myelinolysis, is an uncommon neurological disorder that occurs due to plasma osmotic changes. We present the case of a 55-year-old man, who presented with severe hyponatremia due to repeated vomiting, antidepressant treatment and consumption of large amounts of water. Fifteen days after sodium correction, the patient showed fluctuation of vigilance, dysarthria and dysphagia, tremor, cogwheel rigidity, bilateral facial palsy, ophthalmoplegia and tetraparesis. A brain MRI scan revealed extrapontine and later on pontine myelinolysis. He received intravenous steroids and subsequently immunoglobulin. His status began to improve gradually after completion of immunoglobulin and at three month-follow-up had no neurological deficit. A comprehensive literature search of all reported ODS cases that received immunoglobulin, steroids or plasmapheresis was conducted in the electronic databases PubMed and Web of science. Improvement was seen in most cases that received immunoglobulin either during treatment or in the first days after treatment. With regard to steroids, although most cases reported improvement in the following months their effect on the outcome is unclear. Most cases treated with plasmapheresis reported favorable outcome at variable follow-up time. Immunoglobulin and steroids have immunomodulatory effects, which could contribute to promotion of myelin repair in ODS. Plasmapheresis has effects on the immune system beyond removing myelinotoxins from the circulation. More evidence is required to support their use in ODS. However, in view of the disease severity, these therapeutic choices should be considered in the clinical management of ODS. •Osmotic demyelination syndrome (ODS) is an uncommon life-threatening neurological disorder.•Most ODS cases treated with immunoglobulins, steroids or plasmapheresis had favorable outcome.•Immunoglobulin and steroids may contribute to promotion of myelin repair in ODS.•Plasmapheresis has effects on the immune system beyond removing myelinotoxins from the circulation.•More evidence is needed regarding the use of immune-modulatory treatment in ODS.

Background Restless Legs Syndrome is very common in hemodialysis patients however there are no comparative studies assessing the effectiveness of a non-pharmacological treatment to a classical treatment on parameters related to syndromes’ severity and quality of life. Methods In this randomized, partially double blind, placebo controlled trial, thirty two hemodialysis patients with restless legs syndrome were randomly assigned into three groups: 1) the exercise training group (N = 16), 2) the dopamine agonists group (ropinirole 0.25 mg/d) (N = 8) and 3) the placebo group (N = 8). The intervention programs lasted 6 months. Restless Legs Syndrome severity was assessed using the international severity scale, physical performance by a battery of tests, muscle size and composition by computed tomography, body composition by Dual Energy X Ray Absorptiometry, while depression score, sleep quality, daily sleepiness and quality of life were assessed through questionnaires. Results Exercise training and dopamine agonists were effective in reducing syndrome’s symptoms by 46% (P = 0.009) and 54% (P = 0.001) respectively. Within group changes revealed that both approaches significantly improved quality of life (P < 0.05), however, only the dopamine agonists significantly improved sleep quality (P = 0.009). Within group changes showed a tendency for lean body mass improvements with dopamine agonists, this reached statistical significance only with the exercise training (P = 0.014), which also reduced fat infiltration in muscles (P = 0.044) and improved physical performance (P > 0.05) in various tests. Between group changes detect significant improvements with both exercise and dopamine agonists in depression score (P = 0.003), while only the dopamine agonist treatment was able to significantly improve sleep quality, compared to exercise and placebo (P = 0.016). Conclusions A 6-month exercise training regime was as effective as a 6-month low dosage dopamine agonist treatment in reducing restless legs syndrome symptoms and improving depression score in uremic patients. Further research is needed in order to show whether a combination treatment could be more beneficial for the amelioration of RLS. Trial registration NCT00942253

Background/Objectives: Hemodialysis patients are disproportionately affected by impaired cognitive function in comparison to the general population. This systematic review aims to update and expand the current evidence regarding the effects of IET interventions on global cognition and specific cognitive domains, such as executive function, processing speed, and attention. Methods: A comprehensive search was conducted across three databases (PubMed, Scopus, and EBSCO) from database inception to 24 August 2025 for randomized controlled trials examining the effects of intradialytic exercise training on cognitive function, using combinations of the following search terms: hemodialysis, dialysis, dialy*, physical exercise, physical activity, exercise, activity, activit*, cognition, cognitive, and cognit*. Included studies were assessed for risk of bias and methodological quality using the Jadad Scale and NHLBI tools. Results: Seven studies were included in this review, encompassing (n = 332; 60.4% male) hemodialysis patients aged from 48 to 74.9 years. In comparison to standard care, IET significantly improved global cognition and specific cognitive domains. Regarding global cognitive function, interventions regardless of exercise type, which were performed thrice weekly over 12 to 16 weeks, significantly improved scores in (n = 4; 57%) studies using the Montreal Cognitive Assessment (MoCA) and in (n = 1; 14%) study using the Mini Mental State Examination. Regarding specific cognitive domains, aerobic exercise performed thrice weekly for 12 weeks were associated with statistically significant improvements in the following: executive function scores (n = 2; 29%), studied using the Trail Making Test (TMT) Part-B and TMTB-A; psychomotor processing speed (n = 1; 14%), studied using TMT-A and Symbol Digit Modality Test (SDMT); and alertness (n = 1; 14%), studied using the Test of Attentional Performance (TAP) test. Conclusions: The collective evidence confers that IET is an effective intervention that may moderately improve global and domain-specific cognitive function or, at the very least, serve in a protective capacity to stem potential future cognitive decline in this population. However, further large-scale randomized controlled trials that place emphasis on standardized reporting of exercise intervention characteristics and cognitive outcome measures are necessary to inform clinical practice.